dacarbazine has been researched along with Cell Transformation, Neoplastic in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.33) | 18.7374 |
1990's | 1 (3.33) | 18.2507 |
2000's | 5 (16.67) | 29.6817 |
2010's | 23 (76.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, CS; Lv, SG; Wang, QX; Wu, MJ; Xiao, B; Xu, B; Ye, MH; Zhu, XG | 1 |
Lenders, N; McCormack, A | 1 |
Cabezas, SS; Dos Santos, SN; Helal-Neto, E; Martínez-Máñez, R; Pinto, SR; Portilho, FL; Pozzo, L; Sancenón, F; Santos-Oliveira, R | 1 |
Furuta, T; Hamada, J; Hayashi, Y; Misaki, K; Nakada, M; Nakanuma, Y; Sato, Y | 1 |
Agostinis, P; Govaere, O; Gremeaux, L; Maes, H; Roskams, T; Stas, M; Van den Broeck, A; van den Oord, JJ; Vankelecom, H; Wouters, J | 1 |
Barzo, P; Cserhati, A; Fodor, E; Hideghety, K; Mozes, P; Szanto, E; Tiszlavicz, L | 1 |
Ahmed, AU; Auffinger, B; Dey, M; Guo, D; Han, Y; Lee, G; Lesniak, MS; Tobias, AL | 1 |
Chen, J; Fu, X; Jiang, D; Shi, L; Wan, Y; Wang, Z | 1 |
Chen, YS; Chen, ZP; Guan, S; Guo, CC; Li, WP; Li, WY; Mou, YG; Sai, K; Wang, J; Yang, QY | 1 |
Mukherjee, J; Ohba, S; Pieper, RO; See, WL | 1 |
Cantelli, E; De Vries, S; Dekker, M; Delzenne-Goette, E; Plug, M; Song, JY; Te Riele, H; Van Der Wal, A; Van Gerwen, B; Wojciechowicz, K | 1 |
Nam, DH; Park, C; Yeom, SY | 1 |
Dempsey, RJ; Kuo, JS; Pointer, KB; Zhang, RR | 1 |
Hirohata, T; Ishii, Y; Matsuno, A | 1 |
Hutchinson, L | 1 |
Baronchelli, S; Bentivegna, A; Butta, V; Cilibrasi, C; Dalprà, L; Lavitrano, M; Redaelli, S; Riva, G | 1 |
Botelho, RV; de Oliveira, MF; Reis, RC; Rotta, JM | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Laquaglia, MP; Modak, S | 1 |
Brathwaite, CD; Sandberg, DI; Zoeller, GK | 1 |
Asano, S; Ishida, Y; Katakami, H; Matsuno, A; Mizutani, A; Murakami, M; Okinaga, H; Ozawa, Y; Takano, K; Yamazaki, K | 1 |
Fukushima, T; Inoue, T; Kawaguchi, H; Komatsu, F; Komatsu, M; Nabeshima, K; Oshiro, S; Tsugu, H | 1 |
Chang, YL; Chen, MT; Chen, YW; Cherng, JY; Chien, Y; Chiou, GY; Chiou, SH; Huang, PI; Lo, WL; Shih, YH; Wang, ML; Yang, YP | 1 |
Chen, Y; Dallaglio, K; Fujita, M; Gonzalez, R; Luo, Y; McCarter, MD; Norris, DA; Robinson, SE; Robinson, WA; Roop, DR; Thompson, DC; Vasiliou, V; Wang, J | 1 |
Consales, A; Garrè, ML; Morana, G; Nozza, P; Piccardo, A; Rossi, A | 1 |
Forini, O; Graziani, G; Lacal, PM; Levati, L; Muzi, A; Ruffini, F; Tentori, L; Vergati, M; Vernole, P | 1 |
Erickson, LC; Gibson, NW; Hickman, JA | 1 |
Cobellis, L; Di Re, E; Grosso, G; Quattrone, P; Raspagliesi, F | 1 |
Bolger, MJ; Kaleem, Z; O'Sullivan, MJ; Swanson, PE; Zutter, MM | 1 |
Ebsen, M; Kirchner, EM; Kirchner, J; Theegarten, D; Voigtmann, R | 1 |
Chen, SH; Liang, YC; Lin, CL; Liu, JD; Tsai, SH | 1 |
2 review(s) available for dacarbazine and Cell Transformation, Neoplastic
Article | Year |
---|---|
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).
Topics: Adenoma; Animals; Cell Transformation, Neoplastic; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide | 2018 |
Treatment of pituitary carcinomas and atypical pituitary adenomas: a review.
Topics: Adenoma; Administration, Oral; Antineoplastic Agents, Alkylating; Cell Transformation, Neoplastic; Combined Modality Therapy; Dacarbazine; Disease Progression; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms; Temozolomide | 2014 |
28 other study(ies) available for dacarbazine and Cell Transformation, Neoplastic
Article | Year |
---|---|
SNORD47, a box C/D snoRNA, suppresses tumorigenesis in glioblastoma.
Topics: Adult; Aged; Animals; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Dacarbazine; Disease Models, Animal; Disease Progression; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Mice; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prognosis; RNA, Small Nucleolar; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dacarbazine; Diagnosis, Differential; Early Detection of Cancer; Humans; Isotope Labeling; Magnets; Melanoma; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Porosity; Silicon Dioxide; Technetium; Tomography, Emission-Computed, Single-Photon | 2018 |
Molecular analysis of a recurrent glioblastoma treated with bevacizumab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dacarbazine; Fatal Outcome; Frontal Lobe; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Middle Aged; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-akt; Temozolomide; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Melanoma; Mice; Mice, SCID; Neoplasm Proteins; Neoplasm Staging; Neoplasm Transplantation; Neoplastic Stem Cells; Nuclear Proteins; Repressor Proteins; Side-Population Cells; Skin Neoplasms; Tumor Burden | 2013 |
Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.
Topics: Adult; Brain Neoplasms; Cell Transformation, Neoplastic; Cerebrospinal Fluid; Chemotherapy, Adjuvant; Child, Preschool; Craniospinal Irradiation; Dacarbazine; Female; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Neurocytoma; Radiotherapy, Adjuvant; Temozolomide; Young Adult | 2014 |
Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Dacarbazine; Glioblastoma; Humans; Male; Mice, Nude; Neoplastic Stem Cells; Phenotype; Temozolomide; Xenograft Model Antitumor Assays | 2014 |
miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Cell Transformation, Neoplastic; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MicroRNAs; Neoplastic Stem Cells; Temozolomide | 2014 |
Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Dacarbazine; Disease Models, Animal; Diterpenes; Drug Synergism; Epoxy Compounds; Glioma; Humans; Mice; Neoplasm Transplantation; NF-kappa B; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Stimulation, Chemical; Temozolomide; Transcription, Genetic; X-Linked Inhibitor of Apoptosis Protein | 2014 |
Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.
Topics: Cell Line, Tumor; Cell Transformation, Neoplastic; Dacarbazine; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Glioma; Homologous Recombination; Humans; Isocitrate Dehydrogenase; Mutation; Rad51 Recombinase; Temozolomide | 2014 |
Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Topics: Adenocarcinoma; Adenoma; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Colorectal Neoplasms, Hereditary Nonpolyposis; Dacarbazine; Disease Models, Animal; DNA Mismatch Repair; Female; Intestinal Mucosa; Intestines; Male; Mice, Knockout; MutS Homolog 2 Protein; Neoplastic Stem Cells; Risk Factors; Temozolomide; Time Factors | 2014 |
RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Nucleus; Cell Transformation, Neoplastic; Dacarbazine; Drug Resistance, Neoplasm; Endosomes; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Prognosis; Protein Stability; Protein Transport; ras Proteins; Spheroids, Cellular; STAT3 Transcription Factor; Temozolomide; Tumor Cells, Cultured | 2014 |
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Transformation, Neoplastic; Dacarbazine; Glioma; Humans; Mutation; Neoplasm Recurrence, Local; Temozolomide | 2014 |
Skin cancer. Golden age of melanoma therapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cell Transformation, Neoplastic; Dacarbazine; Female; Humans; Male; Melanoma; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins B-raf | 2015 |
Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Shape; Cell Survival; Cell Transformation, Neoplastic; Dacarbazine; DNA Methylation; Drug Resistance, Neoplasm; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Neoplastic Stem Cells; Promoter Regions, Genetic; Temozolomide; Valproic Acid | 2016 |
Malignant transformation of low-grade gliomas in patients undergoing adjuvant therapy.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Cell Transformation, Neoplastic; Chemoradiotherapy, Adjuvant; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Radiotherapy; Temozolomide | 2017 |
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Combined Modality Therapy; Dacarbazine; Female; Humans; Myelodysplastic Syndromes; Neoplasm Metastasis; Neuroblastoma; Recurrence; Temozolomide | 2008 |
Malignant transformation of an optic pathway glioma without prior radiation therapy.
Topics: Antineoplastic Agents, Alkylating; Cell Transformation, Neoplastic; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Fatal Outcome; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Neoplasms, Radiation-Induced; Optic Chiasm; Optic Nerve; Optic Nerve Glioma; Radiotherapy, Adjuvant; Temozolomide | 2010 |
A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report.
Topics: Antineoplastic Agents, Alkylating; Carcinoma; Cell Transformation, Neoplastic; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Mutation; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |
Radiation-induced astrocytoma with rapid malignant transformation: case report.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Basal Ganglia; Brain Neoplasms; Cell Transformation, Neoplastic; Cerebellar Neoplasms; Dacarbazine; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hydrocephalus; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide; Time Factors; Young Adult | 2011 |
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
Topics: 3' Untranslated Regions; Aged; Base Sequence; Cell Transformation, Neoplastic; Dacarbazine; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Glioblastoma; Humans; Male; MicroRNAs; Middle Aged; Molecular Sequence Data; Neoplastic Stem Cells; Octamer Transcription Factor-3; Polyethyleneimine; Polyurethanes; Radiation Tolerance; SOXB1 Transcription Factors; Temozolomide | 2012 |
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Aldehyde Oxidoreductases; Animals; Apoptosis; Cell Transformation, Neoplastic; Dacarbazine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Isoenzymes; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neoplastic Stem Cells; Response Elements; Retinal Dehydrogenase; RNA, Small Interfering; Skin Neoplasms; Temozolomide; Tretinoin | 2012 |
Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treate
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Child, Preschool; Dacarbazine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Ganglioglioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Temozolomide | 2013 |
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.
Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Polyomavirus Transforming; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Line; Cell Line, Transformed; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Dacarbazine; DNA-Binding Proteins; Endothelial Cells; Flow Cytometry; Gene Expression; HT29 Cells; Humans; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Neoplasms, Experimental; Plasmids; Platelet Endothelial Cell Adhesion Molecule-1; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Telomere; Temozolomide; Transfection; Transplantation, Heterologous; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; von Willebrand Factor | 2005 |
DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.
Topics: Cell Division; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Dacarbazine; DNA; Embryo, Mammalian; Humans; Imidazoles; Kinetics; Nitrogen Mustard Compounds | 1984 |
Malignant degeneration in leiomyomatosis peritonealis disseminata.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Dacarbazine; Epirubicin; Female; Humans; Ifosfamide; Leiomyomatosis; Middle Aged; Peritoneal Neoplasms | 1996 |
Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Reed-Sternberg Cells; Vinblastine | 2000 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Rituximab; Vinblastine; Vincristine | 2001 |
Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catechin; Cell Aggregation; Cell Communication; Cell Movement; Cell Transformation, Neoplastic; Dacarbazine; Drug Screening Assays, Antitumor; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Growth Inhibitors; Injections, Intraperitoneal; Lung Neoplasms; Male; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Neoplasm Transplantation; Phosphorylation; Protein-Tyrosine Kinases; Survival Rate; Tea; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrosine | 2001 |